Neumora Therapeutics Common Stock Statistics Share Statistics Neumora Therapeutics Common Stock has 161.75M
shares outstanding. The number of shares has increased by 1.07%
in one year.
Shares Outstanding 161.75M Shares Change (YoY) 1.07% Shares Change (QoQ) -0.14% Owned by Institutions (%) 37.64% Shares Floating 65.29M Failed to Deliver (FTD) Shares 1,700 FTD / Avg. Volume 0.11%
Short Selling Information The latest short interest is 9.03M, so 5.58% of the outstanding
shares have been sold short.
Short Interest 9.03M Short % of Shares Out 5.58% Short % of Float 15.43% Short Ratio (days to cover) 4.87
Valuation Ratios The PE ratio is -6.93 and the forward
PE ratio is -1.47.
Neumora Therapeutics Common Stock's PEG ratio is
-2.58.
PE Ratio -6.93 Forward PE -1.47 PS Ratio 0 Forward PS 68.4 PB Ratio 5.89 P/FCF Ratio -9.23 PEG Ratio -2.58
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Neumora Therapeutics Common Stock.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 10.51,
with a Debt / Equity ratio of 0.01.
Current Ratio 10.51 Quick Ratio 10.51 Debt / Equity 0.01 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.22M Employee Count 110 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 178K Effective Tax Rate -0.07%
Stock Price Statistics The stock price has increased by -87.1% in the
last 52 weeks. The beta is 2.95, so Neumora Therapeutics Common Stock's
price volatility has been higher than the market average.
Beta 2.95 52-Week Price Change -87.1% 50-Day Moving Average 1.24 200-Day Moving Average 3.74 Relative Strength Index (RSI) 45.72 Average Volume (20 Days) 1,513,251
Income Statement
Revenue n/a Gross Profit n/a Operating Income -263.46M Net Income -243.79M EBITDA -242.98M EBIT -243.61M Earnings Per Share (EPS) -1.53
Full Income Statement Balance Sheet The company has 142.15M in cash and 1.85M in
debt, giving a net cash position of 140.29M.
Cash & Cash Equivalents 142.15M Total Debt 1.85M Net Cash 140.29M Retained Earnings -947.22M Total Assets 223.82M Working Capital 201.75M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -182.94M
and capital expenditures 0, giving a free cash flow of -182.94M.
Operating Cash Flow -182.94M Capital Expenditures n/a Free Cash Flow -182.94M FCF Per Share -1.15
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
